Prevention for Drug Shortages.
FDA Update Prevention for Drug Shortages Being Addressed Notifying FDA of a Discontinuance or Interruption in Manufacturing of Finished Products or Active Pharmaceutical Ingredients Under Section 506C of the FD&C Act” Guidance for Industry The U.S. Food and Drug Administration announced the availability of a draft guidance to help prevent and mitigate drug shortages, titled: